Research ID
hum0553-v1Release info
Research title
Study of anti-malignant cancer drug target using human CRC patient samples
Research overview
- Aims
- Gastrointestinal cancer is the leading cause of cancer-related death, and the 5-year survival rate drops significantly for patients with metastasis. To study the mechanisms of malignant progression, tumor samples are collected from patients at different stages and organoids are established. Using these organoids, anti-cancer drug targets are identified by gene expression analysis, or PDX model analysis, drug screening analysis.
- Methods
- Whole exome sequencing, RNA sequencing
- Participants/materials
- A colorectal cancer patient who underwent surgical resection of liver metastasis.
- URL
- N/A
Datasets
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD001019 | NGS (Exome, RNA-seq) |
| Controlled-access (Type I) |
Data provider
- Principal investigator
- Masanobu Oshima
- Affiliation
- Nano Life Science Institute, Kanazawa University
Research projects
| Name | URL |
|---|---|
N/A | N/A |
Grants
| Name | Title | Project number |
|---|---|---|
KAKENHI Grant-in-Aid for Scientific Research (A) | Mechanisms of Gastric cancer Progression and Metastasis Driven by Exogenous Ligand-dependent Wnt Signaling |
|
KAKENHI Grant-in-Aid for Scientific Research (C) | Intratumoral Microenvironment Associated with Heterogenous accumulation of Mutant p53 |
|
Related publications
No related publications.
Controlled access users
No use of the controlled access data has been recorded.